Matica Bio, VaxDome partner on antiviral hybrid vaccine development
--------------------------------------------------------------------
Source: The Korea Herald
Published: 2026-07-07 14:04 UTC+10:00
Section: All News
Factuality Score: 100
Opinion Category: Neutral
Topics: Health, Property, World News
--------------------------------------------------------------------
Snippet:
Matica Biotechnology, the US contract development and manufacturing organization subsidiary of CHA Biotech, has partnered with Texas-based VaxDome Inc. to jointly develop an antigen-agnostic antiviral vaccine aimed at protecting against a broad range of infectious diseases.
--------------------------------------------------------------------